Talphera (TLPH) Asset Writedowns and Impairment (2015 - 2023)
Talphera (TLPH) posted quarterly Asset Writedowns and Impairment of $1.1 million for Q1 2023, up 1009.38% quarter-over-quarter from $96000.0 in Q4 2019.
Talphera (TLPH) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends
Talphera's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2023.
- In Q1 2023, Asset Writedowns and Impairment changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2023 stood at $1.1 million (changed N/A YoY), while the FY2023 annual figure was $6.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2023 stood at $1.1 million, up from $96000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.1 million in Q1 2023, with the low at $96000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2019 | 96,000.00 |
| Dec 31, 2019 | 96,000.00 |
| Sep 30, 2019 | 900,000.00 |
| Sep 30, 2019 | 900,000.00 |
| Sep 30, 2015 | 500,000.00 |
| Sep 30, 2015 | 500,000.00 |